Joyvie Health Raises $1.04M to Redesign Continence Care

Jan de Vries · 2026-06-05

A UK-based startup called Joyvié Health just closed its pre-Seed funding round, pulling in a total of $1.04 million. That money is going toward a new kind of continence underwear—one that's built from the ground up to cut down on stool-to-skin contact, keep skin healthy, and make life easier for caregivers. The funding comes from a mix of sources: an Innovate UK grant, plus investments from HERmesa Angels, SyndicateRoom, Lavender Ventures, and a few individual angel investors. “Products designed for care should never cause harm. That’s not a vision statement. It’s the reason this company exists,” says Zoe Robson, Founder & CEO of Joyvié Health. ### A Personal Story Behind the Mission Joyvié Health was born out of a deeply personal loss. Zoe Robson founded the company after her father, Fred, passed away in 2025. Fred was 77, fit, and sharp-minded. Then, on Christmas Eve 2024, he got a late-stage pancreatic cancer diagnosis out of nowhere. Eleven weeks later, he was gone. During those eleven weeks, Fred lost bowel control and had to wear a nappy. When feces gets trapped against skin, it breaks down fast—moisture, pathogens, and pH imbalances do damage that never fully heals. His skin broke down. His dignity went with it, change by change. And Ruth, his wife and primary caregiver, carried a burden that was invisible to the outside world and impossibly heavy. “My parents didn’t deserve that,” says Zoe. “They were both at their most vulnerable—and the product meant to help them was making it worse. The skin breakdown, the shame, the loss of dignity, the weight on my mum. It wasn’t from lack of care. It’s a design failure.”  ### How the Product Works Differently The company’s mission is to end the silent humiliation of fecal incontinence (FI)—a condition that affects an estimated 656 million people worldwide. Yet the most common non-invasive solution hasn’t changed in decades: nappies and pads. Here’s where Joyvié’s approach breaks the mold: - Existing products trap feces against the skin, causing irritation and breakdown. - Joyvié’s underwear contains stool in a disposable pouch right after excretion. - This significantly reduces skin contact, preserves dignity, and cuts care time. - Early testing shows about 90% reduction in stool-to-skin contact and roughly 70% faster changes. ### Broader HealthTech Funding Trends in 2026 Joyvié’s pre-Seed round is part of a bigger wave of HealthTech funding across the UK and Europe this year. Other companies in adjacent areas—like care delivery, clinical workflow, elderly care, medical devices, and women’s health—are also raising big money. In the UK: - Semble raised $40.5 million to scale its healthcare management platform for outpatient providers. - Evaro secured $24.5 million to expand NHS-licensed embedded health services. - JAAQ closed $17.5 million to grow enterprise partnerships. - Calibre emerged from stealth with $3.3 million to tackle health “guesswork.” - Nul raised $980,000 to launch and expand its alcohol-dependence care platform. Elsewhere in Europe: - Recare in Berlin raised up to $43.2 million to scale its AI platform for hospitals and care providers. - Patronus raised $12.8 million for a senior-friendly emergency smartwatch and family app. - Tucuvi raised $19.8 million to scale voice-AI nursing follow-up automation. - Ditto in Rotterdam raised $8.9 million to make medical information easier for patients to understand. - ShanX Medtech secured $28 million to advance antimicrobial-resistance diagnostics, with an initial women’s-health application in urinary tract infections. - MedVasc raised $2.6 million to progress its anesthesia catheter toward U.S. approval. All together, these rounds add up to over $202 million in related 2026 HealthTech funding. ### What Investors See in Joyvié “At Lavender Ventures, we are committed to backing founders addressing large, underserved markets with innovative solutions that can meaningfully improve people’s lives,” says Gail Armstrong from Lavender Ventures. “We believe the market is ripe for innovation, and Joyvié’s approach has the potential to deliver significant benefits not only for individuals, but also for carers, healthcare systems, and the environment.” Fecal incontinence is often caused by things like surgery, childbirth, chronic illness, or aging. For millions of people, it’s a daily struggle that’s rarely talked about. Joyvié is trying to change that—starting with a product that actually works for the people who need it most.